CalbaTech, which recently acquired oligo and reagent provider Molecula Research Laboratories, said this week that it has appointed Paul Heaney to its scientific advisory board.
Heaney received a PhD in medicinal chemistry from the University of Glasgow, said CalbaTech, and has held senior research and development positions at Amersham International (now Amersham Biosciences), Kodak Clinical Diagnostics (now Ortho-Clinical Diagnostics), Genometrix, Orchid Biosciences, and Sequenom.